MIR3142

Across TCGA pan-cancer cohorts, MIR3142 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MIR3142 data layer compared with 1 for mutation status.

The strongest signal is observed in brain lower grade glioma (LGG), where higher MIR3142 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3142 expression acts as an unfavorable survival marker, although some lineages such as OV and STAD show a favorable association.

LGG, OV, and STAD are the cancer types where MIR3142 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	OS	Tertile	All	0.318	0.834	<.001	36	view →
OV	DFS	Tertile	III,IV	1.000	0.147	.008	30	view →
STAD	OS	Tertile	All	0.848	0.639	.018	15	view →
SKCM	DFS	Tertile	IV	0.040	0.432	.038	9	view →
ESCA	DFS	Tertile	III,IV	0.605	0.275	.033	9	view →
SARC	DFS	Tertile	All	0.127	0.611	.049	9	view →
KIRC	OS	Tertile	All	0.691	0.881	.045	6	view →
KIRP	OS	Tertile	All	0.192	0.705	.017	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

MIR3142–LGG (OS)

Open the LGG breakdown →